3-rx.comCustomer Support
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics

\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>

Join our Mailing List


You are here : 3-RX.com > Home > Brain - Neurology -

Meth abuse may speed age-related brain degeneration

Brain • • NeurologyAug 28, 07

Young people who abuse methamphetamines may put themselves at risk of parkinson-like movement disorders later in life, a new animal study suggests.

In experiments with mice, scientists found that animals deficient in a protein called glial cell line-derived neurotrophic factor (GDNF) were especially vulnerable to long-term movement problems after being exposed to the neurotoxic effects of a methamphetamine “binge.”

GDNF is needed for the proper functioning of dopamine, a brain chemical involved in regulating movement. Both GDNF and dopamine are depleted in the brains of people with Parkinson’s disease.

Because methamphetamines can damage dopamine-producing cells in the brain, researchers have speculated that young meth users may be at elevated risk of parkinson-like movement disorders as they age.

The new findings, reported in The Journal of Neuroscience, support that theory.

“The study in mice tells us that people who make less GDNF protein may be more vulnerable to the motor deficits caused by methamphetamine and that those effects may not be revealed until we get older,” explained principal author Dr. Jacqueline McGinty, a professor in the department of neurosciences at the Medical University of South Carolina in Charleston.

For their study, McGinty and her colleagues used both normal mice and mice missing one of their genes for GDNF. Two weeks after being exposed to a meth binge, the animals tended to show dopamine depletion and other signs of brain damage, with the GDNF-deficient mice being especially vulnerable.

Similarly, these mice were more likely to have movement impairments when they were 12 months old—old age for rodents.

No one knows what percentage of the population has an abnormal GDNF gene, McGinty told Reuters Health, but individuals certainly vary in how much GDNF protein their genes make.

It’s possible, she and her colleagues say, that young people with naturally lower levels of the protein may be susceptible to long-term brain damage and Parkinson-like symptoms at an older age.

“Motor deficits during aging may be accelerated if young adults are exposed to an environmental toxin like methamphetamine,” McGinty said.

SOURCE: The Journal of Neuroscience, August 15, 2007.

Print Version
comments powered by Disqus

  Large doses of antioxidants may be harmful to neuronal stem cells
  Repairing the cerebral cortex: It can be done
  UTSW researchers identify a therapeutic strategy that may treat a childhood neurological disorder
  Train your heart to protect your mind
  Sleep Loss Accelerates Brain Aging: Study
  To advance care for patients with brain metastases: Reject five myths
  Study Explains How High Blood Pressure in Middle Age Affects Memory in Old Age
  Study Reveals Evolution at Work
  Study reveals workings of working memory
  Family problems experienced in childhood and adolescence affect brain development
  Researchers find retrieval practice improves memory in severe traumatic brain injury
  Study finds axon regeneration after Schwann cell graft to injured spinal cord


Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site